Elekta's Nucletron division has completed the first U.S. installation of its Esteya electronic brachytherapy system.
Memorial Sloan-Kettering Cancer Center in New York City received the system. It will lead a multicenter clinical study with the goal of further improving skin cancer treatment, Elekta said.
